Isotretinoin for acne: benefits, pregnancy safety and follow-up
Isotretinoin is an oral prescription medicine used for selected severe or difficult-to-treat acne. It can be useful when the risk of scarring or the burden of disease is substantial, but it needs an individual assessment, safety discussion and follow-up. Pregnancy prevention is essential when pregnancy is possible. Having PCOS neither makes isotretinoin automatically appropriate nor rules it out.
Contents
Isotretinoin is an oral retinoid, not an antibiotic
Isotretinoin acts on processes involved in acne, including oil-gland activity. Roaccutane and Accutane are names people may use when referring to it, but you should check the actual ingredient and formulation on the package. Topical tretinoin, cosmetic retinol and oral isotretinoin are not interchangeable. AAD isotretinoin information.
The medicine treats active acne; it does not directly release a tethered scar or replace the assessment of another rash. A promise of a permanent cure for everyone does not describe an individual treatment decision. Ask what benefit is realistic for your acne and what follow-up will be needed.
When might a dermatologist consider it?
Severe nodular acne, risk of permanent scarring or disease that has not responded adequately to appropriate treatment can lead to consideration of isotretinoin. Assessment includes more than the number of spots on today’s photograph. Previous treatment, tolerability, adherence and the effect on life matter. AAD acne treatment guideline.
Bring enough detail to distinguish a completed course that did not help from a medicine stopped early because of irritation or uncertainty. An acne-like disorder can also explain a poor response. The dose, length of treatment and choice of medicine belong to the prescriber; do not copy an online schedule or use another person’s capsules.
Can isotretinoin be used for acne in someone with PCOS?
The decision concerns the acne and the person’s overall circumstances. Isotretinoin is not a treatment for irregular ovulation, insulin resistance or PCOS itself. Skin treatment and reproductive or metabolic care may need to proceed together rather than expecting one medicine to answer every symptom.
Explain menstrual changes, other hormonal symptoms, current contraception, fertility plans and other medicines. Irregular or absent periods do not remove the possibility of pregnancy. For the broader context, see the English PCOS, skin and hair guide.
Does a menstrual change during treatment mean isotretinoin caused PCOS?
No single change in bleeding pattern, nor its timing after a medicine starts, establishes PCOS or proves the medicine caused it. Menstrual changes should be reported and assessed in context, including pregnancy possibility, the history before treatment and other medicines. Do not dismiss the symptom or diagnose yourself from a forum post.
The patient-safety guidance cited here establishes an acne indication and monitoring needs; it does not provide a basis for diagnosing PCOS from isotretinoin exposure. If a new reproductive symptom appears, ask the prescriber how it should be investigated and whether another clinician should be involved. The English testing guide explains the limits of individual test results.
Pregnancy, planning pregnancy and breastfeeding
Isotretinoin must not be taken during pregnancy, when trying to become pregnant or while breastfeeding. It can seriously harm a developing baby. When pregnancy is possible, a clinician must explain effective contraception and the required pregnancy-testing plan before and during treatment. Contraception is needed before treatment and after stopping; the NHS guidance specifies at least one month before and one month after. NHS isotretinoin safety guidance.
If you think you may be pregnant during treatment, stop taking isotretinoin and contact the prescriber urgently. If contraception fails or the pregnancy-prevention plan cannot be followed, seek prompt professional advice rather than waiting for the next routine visit. Requirements should be explained for your actual place of care and product.
What to tell the clinician before starting
- Your previous acne treatments and what happened with each.
- All prescribed medicines, vitamins, supplements and herbal products.
- Pregnancy possibility, breastfeeding and plans to conceive.
- Liver or lipid problems, allergies and other health conditions.
- Your mental-health history and any concerns about mood or sexual function.
- Upcoming skin procedures, hair removal or events that affect care.
These are topics for a confidential medical discussion, not a reason to leave out treatment options yourself. Bring results already available and ask which new tests would change the decision. Do not arrange a universal panel or change prescriptions without instructions.
What are check-ups and tests trying to establish?
Follow-up checks response, tolerability and safety. Blood tests and pregnancy-related monitoring depend on clinical circumstances and the applicable programme. The clinician should explain the plan and who to contact between appointments.
MHRA’s January 2026 safety update continues to emphasise assessment and monitoring of mental health and sexual-function concerns, alongside pregnancy prevention. This is UK guidance, not a description of Iranian administrative rules. It supports a practical question for your own visit: what changes should I report and how quickly? MHRA 2026 safety update.
Dryness and a manageable daily routine
Dry lips, skin and eyes are common concerns; sun sensitivity can also occur. Gentle cleansing, suitable moisturiser, lip care and sun protection can help tolerability. Tell the clinician if eye discomfort, nosebleeds or dryness is persistent. Do not add harsh exfoliants or several drying acne products to make the treatment “stronger.”
Have the routine checked against your prescription. The same product combination used before treatment may no longer be comfortable. Keep a short list of the problems that interfere with daily use; that is more useful than silently enduring them or changing the dose yourself.

When should I seek help before the next visit?
Seek prompt medical advice for significant new mood or sexual-function changes, persistent troublesome side effects or a pregnancy concern. Thoughts of self-harm, severe mental-health symptoms, severe abdominal pain, breathing difficulty, a seizure or signs of a serious allergic reaction need urgent medical help. Use local emergency services when immediate safety is at risk.
Do not wait for a routine blood test or try to explain a serious symptom as ordinary treatment dryness. Tell the treating team what medicine you took, when symptoms began and what other products you use. Follow the urgent instructions in the product leaflet and your prescriber’s plan.
Capsules, forgotten doses and planned procedures
Use the instructions for the exact formulation supplied. Ask the pharmacist about food requirements and how to handle a missed dose; do not take a double dose to compensate. Taking more than prescribed needs urgent medical advice, even before symptoms appear.
Vitamin A supplements and certain antibiotics may interact with isotretinoin, so the full medication list matters. Tell anyone planning a peel, laser procedure, waxing or scar treatment about current and recent use. Obtain an individual plan rather than assuming a universal safe interval. Do not donate blood during treatment or within the period specified by the prescriber and product guidance.
Early worsening, relapse and specific follow-up questions
Acne may temporarily worsen early in treatment. Rapidly worsening painful lesions or feeling unwell should be reported rather than assumed to be a normal “purge.” Acne returning after the course is a different question; see the relapse and maintenance guide in Persian. Do not restart leftover capsules yourself. Roaccutane patient leaflet
Liver enzymes and blood lipids are checked for drug safety; pregnancy tests have a separate purpose. Your clinician should explain the plan for each. Keep the dates of your tests, dose changes and last capsule available for follow-up. The Persian guides explain liver and blood-test monitoring and pregnancy and fertility safety.
Tell the prescriber about doxycycline or other tetracyclines and vitamin A supplements. Do not donate blood during treatment or for one month after stopping. Procedure timing depends on the exact method and device instructions; see the procedure guide in Persian. For practical skin and lip care, use the treatment routine in Persian. These links supplement your individual plan. British Association of Dermatologists patient guidance
Bring your medicine package, test results and main concerns to an assessment with Dr Shahverdi; confirm consultation-language availability with the clinic.
Dr Shahverdi’s practical notes
The clinic’s published Persian isotretinoin guide advises explaining pregnancy plans and mental-health concerns from the beginning, agreeing on follow-up and knowing the symptoms that need earlier contact. The decision follows examination and history; a fixed result for every person is not promised.
Questions patients ask
Does a PCOS diagnosis mean I must use isotretinoin?
No. Treatment depends on the acne, previous response, risks and your goals. Hormonal or metabolic care has separate purposes.
Will it remove my existing acne scars?
It treats acne and can help prevent further damage by controlling lesions. Existing scars need their own assessment.
Can I stop once the skin looks clear?
Discuss stopping or adjusting treatment with the prescriber. The agreed course and safety plan should guide the decision.
Is a person’s online dose appropriate for me?
No. A capsule count or body weight alone cannot replace assessment and monitoring.
Arrange an assessment with Dr Shahverdi

Bring previous treatment details, medicine and supplement labels, relevant test results and your main concerns. For an acne assessment with Dr Mohammad Hassan Shahverdi, use the official clinic contact page. Confirm appointment availability and the consultation language. A consultation helps establish suitability; it is not a commitment to prescribe isotretinoin.
Call the clinic: +98 21 2218 5180.